NCT04743479View on ClinicalTrials.gov

Artificial Intelligence-based Early Screening of Pancreatic Cancer and High Risk Tracing (ESPRIT-AI)

RecruitingOBSERVATIONAL
Enrollment

5,000

Participants

Timeline

Start Date

December 1, 2020

Primary Completion Date

December 30, 2025

Study Completion Date

December 30, 2030

Conditions
Pancreatic CancerDiabetesFamilial Pancreatic CancerPancreatic Cystic NeoplasmChronic PancreatitisHereditary Pancreatitis
Interventions
DIAGNOSTIC_TEST

high-resolution MRI/CT examinations

Participants will undergo annual questionnaire survey, laboratory tests and high-resolution MRI/CT examinations of the pancreas. Any suspicious lesions will be further examined by endoscopic ultrasound (EUS).

Trial Locations (1)

200433

RECRUITING

Shanghai Changhai Hospital, Shanghai

All Listed Sponsors
lead

Changhai Hospital

OTHER